Robin Wood

Active 1960–2025

170
Papers
25,621
Citations
100
h-index
167
i10-index

Citations

Citations per year for Robin Wood1988: 1 citations1994: 1 citations1995: 1 citations1997: 8 citations1998: 4 citations1999: 10 citations2000: 10 citations2001: 9 citations2002: 21 citations2003: 47 citations2004: 51 citations2005: 84 citations2006: 133 citations2007: 141 citations2008: 251 citations2009: 257 citations2010: 398 citations2011: 369 citations2012: 318 citations2013: 291 citations2014: 260 citations2015: 239 citations2016: 153 citations2017: 188 citations2018: 143 citations2019: 572 citations2020: 519 citations2021: 392 citations2022: 325 citations2023: 176 citations2024: 353 citations2025: 131 citations2026: 7 citations1989–1993: no citations, so these years are not shown1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,913 citing papers, 21.5% of this breakdownSouth Africa: 1,110 citing papers, 12.4% of this breakdownUnited Kingdom: 942 citing papers, 10.6% of this breakdownSwitzerland: 399 citing papers, 4.5% of this breakdownUganda: 296 citing papers, 3.3% of this breakdownCanada: 282 citing papers, 3.2% of this breakdownFrance: 248 citing papers, 2.8% of this breakdownNetherlands: 237 citing papers, 2.6% of this breakdownAustralia: 223 citing papers, 2.5% of this breakdownChina: 193 citing papers, 2.2% of this breakdownGermany: 186 citing papers, 2.1% of this breakdownIndia: 168 citing papers, 1.9% of this breakdown
0%21.5%Other 30.4%

Fields

  • Medicine83.4%
  • Immunology and Microbiology4.8%
  • Health Professions3.2%
  • Biochemistry, Genetics and Molecular Biology1.3%
  • Neuroscience1.3%
  • Engineering1.1%
  • Other4.9%

Topics

  • HIV/AIDS Research and Interventions12.5%
  • Tuberculosis Research and Epidemiology10.6%
  • HIV/AIDS drug development and treatment7.3%
  • HIV Research and Treatment6.5%
  • Pneumocystis jirovecii pneumonia detection and treatment4.4%
  • HIV-related health complications and treatments4.1%
  • Other54.6%

Coauthors

All papers

Open in search
  1. Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katherine C. Horton, Emily A. Kendall, Palwasha Khan, Peter MacPherson, Stephanus T. Malherbe, Vidya Mave, Simon C. Mendelsohn, Munyaradzi Musvosvi, Elisa Nemes, Adam Penn‐Nicholson, Dharanidharan Ramamurthy, Molebogeng X. Rangaka, Suvanand Sahu, Alvaro Schwalb, Divya Shah, Dylan Sheerin, Donald Simon, Adrie J. C. Steyn, Thu Anh Nguyen, Gerhard Walzl, Charlotte Weller, Caroline Williams, Emily Wong, Robin Wood, Yingda L. Xie, Siyan Yi - The Lancet Respiratory Medicine 2024 cited by 157

  2. Aerosolization of Mycobacterium tuberculosis by Tidal Breathing

    Authors: , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2022 cited by 82

  3. RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fazlin Kafaar, Leslie Workman, Humphrey Mulenga, E. Jane Hughes, Onke Xasa, Ashley Veldsman, Yolundi Cloete, Deborah Abrahams, Sizulu Moyo, Sebastian Gelderbloem, Michèle Tameris, Hennie Geldenhuys, Rodney Ehrlich, Suzanne Verver, Larry Geiter, Gillian F. Black, Gian van der Spuy, Kim Stanley, Magdalena Kriel, Nelita du Plessis, Nonhlanhla Nene, Teri Roberts, Léanie Kleynhans, Andrea Gutschmidt, Bronwyn Smith, André G. Loxton, Gerhardus Tromp, David L. Tabb, Tom H. M. Ottenhoff, Michèl R. Klein, Mariëlle C. Haks, Kees L. M. C. Franken, Annemieke Geluk, Krista E. van Meijgaarden, Simone A. Joosten, W. Henry Boom, Bonnie Thiel, Harriet Mayanja-Kizza, Moses Joloba, Sarah Zalwango, Mary Nsereko, Brenda Okwera, Hussein Kisingo, Shreemanta K. Parida, Robert Golinski, Jeroen Maertzdorf, January Weiner, Marc Jacobson, Hazel M. Dockrell, Steven G. Smith, Patricia Gorak‐Stolinska, Yun‐Gyoung Hur, Maeve K. Lalor, Ji‐Sook Lee, Amelia C. Crampin, Neil French, Bagrey Ngwira, Anne Ben‐Smith, Kate E. Watkins, Lyn Ambrose, Felanji Simukonda, Hazzie Mvula, Femia Chilongo, Jacky Saul, Keith Branson, Hassan Mahomed, E. Jane Hughes, Onke Xasa, Ashley Veldsman, Katrina Downing and 169 more - Scientific Reports 2020 cited by 171

  4. Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Suzette Oelofse, Didier Laureillard, Mauro Andreotti, Obvious Nchimunya Chilyabanyama, Benjamin Welu, Lucas Molfino, Sekai Chenai Mathabire Rücker, Elisabeth Szumilin, Loide Cossa, Johanna Meléndez, Linda Mbuthini, Max R. O’Donnell, Joseph N Jarvis, Gcobisa Ndlangalavu, Katherine Fielding - The Lancet Global Health 2023 cited by 86

  5. Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2013 cited by 371

  6. Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis

    Authors: , , , , , , , , , - AIDS 2012 cited by 286

  7. Drivers of Tuberculosis Transmission

    Authors: , , , , , , , , - The Journal of Infectious Diseases 2017 cited by 195

  8. Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Faiz Ahmad Khan, Andrea A Howard, Robin Wood, Swe Swe Thit, Mar Mar Kyi, Josh Hanson, Paul K Drain, Adrienne E Shapiro, Tendesayi Kufa, Gavin Churchyard, Duc T Nguyen, Edward A Graviss, Stephanie Bjerrum, Isik S Johansen, Jill K Gersh, David J Horne, Sylvia M LaCourse, Haider Abdulrazzaq Abed Al-Darraji, Adeeba Kamarulzaman, Russell R Kempker, Nestani Tukvadze, David A Barr, Graeme Meintjes, Gary Maartens - The Lancet Infectious Diseases 2021 cited by 70

  9. Tuberculosis Incidence Rates during 8 Years of Follow-Up of an Antiretroviral Treatment Cohort in South Africa: Comparison with Rates in the Community

    Authors: , , , , - PLoS ONE 2012 cited by 247

  10. Mycobacterium tuberculosis Transmission in High-Incidence Settings—New Paradigms and Insights

    Authors: , , , , - Pathogens 2022 cited by 80

  11. Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study

    Authors: , , , , , , , , , , , - The Lancet Respiratory Medicine 2017 cited by 149

  12. Is cough really necessary for TB transmission?

    Authors: , - Tuberculosis 2019 cited by 127

  13. Trends in CD4 and viral load testing 2005 to 2018: multi‐cohort study of people living with HIV in Southern Africa

    Authors: , , , , , , , , , , , , , , , , , - Journal of the International AIDS Society 2020 cited by 50

  14. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa

    Authors: , , , , - AIDS 2009 cited by 344

  15. The transmission of Mycobacterium tuberculosis in high burden settings

    Authors: , , , , , , , , , , , - The Lancet Infectious Diseases 2016 cited by 195

  16. Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Global Health 2020 cited by 116

  17. Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosols

    Authors: , , , , , , , , , , , , , , , , , , - PLoS Pathogens 2021 cited by 61

  18. Aerosolization of viable Mycobacterium tuberculosis bacilli by tuberculosis clinic attendees independent of sputum-Xpert Ultra status

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2024 cited by 31

  19. The Dynamics of QuantiFERON-TB Gold In-Tube Conversion and Reversion in a Cohort of South African Adolescents

    Authors: , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2015 cited by 144

  20. Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential

    Authors: , , , , , , , , , - Annals of Internal Medicine 2019 cited by 70

  21. Detection, survival and infectious potential ofMycobacterium tuberculosisin the environment: a review of the evidence and epidemiological implications

    Authors: , , , , , , , , , , , , - European Respiratory Journal 2019 cited by 65

  22. Tuberculosis screening among HIV-positive inpatients: a systematic review and individual participant data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet HIV 2022 cited by 42

  23. Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies

    Authors: , , , , , , , , , , , , , - PLoS Medicine 2013 cited by 446

  24. Linkage to HIV, TB and Non-Communicable Disease Care from a Mobile Testing Unit in Cape Town, South Africa

    Authors: , , , , , , , , - PLoS ONE 2013 cited by 96